Home
About
Overview
Sharing Data
ORCID
Help
History (12)
Predictive validity of the ASAM Patient Placement Criteria for hospital utilization.
Phosphodiesterase inhibitor-mediated potentiation of adenovirus delivery to myocardium.
Improving patient-provider communication about chronic pain: development and feasibility testing of a shared decision-making tool.
Regulation of protein kinase CK1alphaLS by dephosphorylation in response to hydrogen peroxide.
Is treatment with a luteinizing hormone-releasing hormone agonist justified in short adolescents?
See All 12 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Is treatment with a luteinizing hormone-releasing hormone agonist justified in short adolescents?
Lee MM. Is treatment with a luteinizing hormone-releasing hormone agonist justified in short adolescents? N Engl J Med. 2003 Mar 06; 348(10):942-5.
View in:
PubMed
subject areas
Adolescent
Body Height
Bone Density
Child
Enzyme Inhibitors
Gonadotropin-Releasing Hormone
Growth Disorders
Humans
Puberty
Triptorelin Pamoate
authors with profiles
Mary M Lee MD